By Justin Fein
Recent changes to federal childhood vaccine recommendations are already influencing conversations in pediatric care, with many clinicians reporting concern about how the updated guidance may affect vaccination decisions, patient trust, and the future incidence of vaccine-preventable disease.
In a recent Konovo survey of 50 pediatric clinicians, including 25 physicians and 25 nurse practitioners, familiarity with the updated recommendations was nearly universal. Seventy-two percent said they were very familiar with the changes, while another 26% described themselves as somewhat familiar. Just 2% were aware of the changes without being familiar with the details, and none said they were unfamiliar.
That high level of awareness makes the response from clinicians particularly notable. The survey suggests the changes are not simply being observed as a policy development; they are beginning to affect day-to-day pediatric practice and the conversations clinicians have with families.
Nearly two-thirds of clinicians said the updated recommendations have changed the way they discuss childhood vaccination with parents or caregivers. Twenty-six percent reported that their conversations have changed significantly, while 38% said they have changed somewhat. The remaining 36% reported little to no change.
Clinicians are also observing an effect on families’ vaccination decisions. Eighty-four percent said they are seeing at least some impact among patients choosing whether or not to vaccinate, including 24% who described the impact as substantial and 60% who said they were seeing somewhat of an impact. Only 12% reported little or no impact, while 4% said it was still too early to tell.
For many clinicians, the concern extends beyond individual conversations and into broader questions about confidence in vaccination, consistency of public health guidance, and protection against diseases that have become uncommon in routine pediatric practice.
When asked to describe their feelings about the guideline changes in a single word, 56% selected “dangerous,” making it the most common response by a wide margin. Another 22% chose “unfounded,” while 12% described the changes as “confusing.” Together, those responses point to substantial concern among the clinicians surveyed.
Their written comments provide additional context. A recurring theme was the possibility that changes in recommendations could contribute to lower vaccination rates and, ultimately, the return or wider spread of vaccine-preventable diseases. Clinicians repeatedly raised concerns about children becoming more vulnerable to illnesses that have become rare, declining herd immunity, and the possibility of future outbreaks.
Several also worried about the effect of changing or inconsistent recommendations on conversations with families. One clinician emphasized the need for “clear, consistent, and easily accessible guidance” as recommendations evolve, noting that risk-based recommendations and shared clinical decision-making can make it more difficult both for providers to determine the appropriate course for an individual patient and for families to understand the guidance.
Others described a practical challenge: clinicians may increasingly need to spend time explaining why a vaccine remains important when parents are hearing different messages from different healthcare or public health organizations. Some raised concerns that changing guidance could create confusion beyond vaccination itself and weaken confidence in healthcare recommendations more broadly.
Implementation was another recurring issue. Clinicians mentioned the need for staff education, updated clinical decision support, clear algorithms, appropriate patient education materials, and alignment between federal recommendations, state-level guidance, professional societies, and available vaccine formulations. A few clinicians said explicitly that they did not plan to change their current recommendations, instead intending to continue following existing state guidance or recommendations from professional medical organizations.
At the same time, the findings are not unanimous.
Although opinion clearly leaned toward concern, a minority of clinicians viewed the changes more favorably. Eight percent characterized the updated recommendations as “justified,” and 2% selected “beneficial.” One clinician described the changes as “long overdue” and welcomed updated clinical data examining the risks and benefits of vaccination, particularly for diseases that have become uncommon in the United States.
That minority perspective is important. The results do not suggest complete agreement among pediatric clinicians about the appropriateness of the new recommendations. Rather, they reveal a field in which the dominant sentiment is one of concern, while a smaller group sees potential value in reassessing existing practices and the evidence behind them.
The clearest point of agreement may therefore be less about whether the changes themselves are appropriate and more about what clinicians need as they navigate them.
Pediatric healthcare professionals are operating in an environment where vaccine recommendations, family questions, and clinical decision-making are increasingly intertwined. Regardless of whether clinicians view the updated guidance as dangerous, confusing, justified, or beneficial, the survey underscores the importance of clarity, consistency, evidence, and practical support.
For clinicians on the front lines of pediatric care, changes in vaccine policy do not remain confined to a recommendation document. They enter the exam room, influence conversations with parents, shape decisions about individual children, and potentially affect confidence in the broader healthcare system.
The findings suggest that as updated childhood vaccine recommendations move from policy into practice, understanding the experiences and concerns of the clinicians responsible for implementing them will be essential.
If you are a healthcare worker that is interested in participating in our paid research studies, please register here.
